Vivos Highlights Undiagnosed Symptoms of Obstructive Sleep Apnea and Their Effects

Obstructive Sleep Apnea (OSA) is a serious sleep disorder that often remains undiagnosed, affecting over a billion people globally. Many individuals with this condition experience disruptive symptoms that are frequently misattributed to other health issues or dismissed as minor concerns. On August 7, 2025, Vivos Therapeutics, based in Littleton, Colorado, emphasized the urgency of recognizing these hidden signs for better health outcomes.

Kirk Huntsman, Chairman and CEO of Vivos, spoke candidly about this neglect, stating that symptoms like night sweats, teeth grinding, and erectile dysfunction may appear trivial but can signify a body in distress. The company is dedicated to assisting healthcare providers in identifying these overlooked symptoms early and facilitating innovative, non-invasive treatments to mitigate OSA's impacts.

The Media Blind Spot

Despite the staggering number of individuals affected by OSA, many stories remain untold. Symptoms such as resistant hypertension, erectile dysfunction, and chronic acid reflux are often dismissed, leading to years of suffering without a proper diagnosis. Research has shown that a significant percentage of people struggling with resistant hypertension—around 80%—have undiagnosed OSA, and untreated conditions can lead to serious complications such as heart attacks or strokes.

“Connecting the dots could change your life,” remarked Huntsman, indicating the necessity of establishing clear links between these symptoms and sleep apnea. Misdiagnosis of OSA remains a substantial public health challenge that Vivos aims to confront.

The Overlooked Symptoms

Many people are unaware that their health anomalies might be tied to sleep apnea. Let’s break down some of the significant yet often ignored signs of OSA:

1. Hypertension: About 80% of patients with resistant hypertension remain undiagnosed with OSA. The prolonged pressure from untreated sleep apnea creates a vicious cycle that complicates blood pressure management.

2. Erectile Dysfunction (ED): OSA impacts approximately 80% of men experiencing erectile dysfunction. By interfering with blood circulation and amplifying systemic inflammation, untreated OSA worsens sexual health and emotional well-being.

3. Acid Reflux: A notable 78% of individuals with sleep apnea report experiencing nighttime acid reflux. This occurs due to negative airway pressure during apneas that can draw stomach acid into the esophagus, resulting in esophageal damage over time.

4. Night Sweats: An alarming one-third of OSA patients suffer from night sweats, often triggered by the body’s fight-or-flight response to diminished oxygen during sleep.

5. Teeth Grinding (Bruxism): This symptom appears in about 50% of adults with OSA. The act of grinding teeth often serves as a reflex, with the body tensing to reopen airways, causing potential dental and jaw issues.

Each of these symptoms represents a crucial opportunity for early diagnosis. Vivos argues that it is imperative for healthcare providers to adopt a more proactive approach in recognizing the nuanced signs of OSA.

Addressing the Crisis: The Vivos Method

Vivos has created a systematic approach to tackle the misdiagnosis problem endemic within the medical community. By informing healthcare professionals about the compounded nature of these symptoms, they aim to shift the focus back onto the holistic impact of OSA on a patient’s overall health. Their innovative method focuses on early recognition, diagnosis, and treatment.

The Vivos Method is centered around a proprietary oral appliance technology that is FDA-cleared. This non-surgical, non-pharmaceutical method remodels the airway within a year, treating OSA effectively while preventing years of misdiagnosis and decline.

Moreover, Vivos offers enhanced access to sleep testing and telemedicine consultations, aiming to address the underlying causes of OSA swiftly. “Uncovering the real cause behind these symptoms isn’t just diagnostic—it’s life-changing. That’s the power of personalized care,” emphasized Huntsman.

About Vivos Therapeutics

Founded in 2016, Vivos Therapeutics is pioneering the conversation around Obstructive Sleep Apnea. With an innovative treatment approach that pairs with education and comprehensive partnerships, Vivos empowers healthcare practitioners to effectively manage the multi-faceted challenges faced by OSA patients. Their commitment to addressing this persistent public health epidemic is commendable, offering hope to individuals with this often-ignored condition.

For more information, visit www.vivos.com.